Gaya APA

Efficacy and safety of evolocumab (AMG 145), a fully humanmonoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials. (). [s.i.]: .

Gaya MLA

Efficacy and safety of evolocumab (AMG 145), a fully humanmonoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials. . [s.i.]: , . Text.